Review of the therapist congress of iQMedix GmbH
An inspiring event for professionals
Full of innovations and scientific findings
On May 10, 2025, the iQMedix GmbH Therapeutic Congress took place in Mannheim, a highlight for medical and therapeutic professionals. The congress offered a comprehensive program with top-class speakers and exciting presentations on innovative approaches in tumor diagnostics and therapy.
Program overview
WELCOME AND INTRODUCTION
The day began with an introduction by Dr. med. Reinhard Becker, Managing Director of iQMedix GmbH. In his presentation on personalized tumor diagnostics using gene expression analysis, new possibilities for increasing the precision of diagnostics and developing personalized treatment strategies were presented.
Scientific lectures
- Dr. rer. nat. Daniel Heylmann presented the latest findings on synthetic lethality in tumor therapy, a promising strategy for the targeted treatment of cancer.
- Dr Jens-Paul Seldte, specialist in gynaecology and obstetrics, spoke about the use of integrative medicine in the treatment of breast diseases, from meditation approaches to individualized medicine.
- Dr. phil. Bojan Godina presented autonomy training, an innovative concept with a bio-psycho-social approach that offers new hope for patients with cancer.
- Dr Anwar Giryes explained how integrative personalized tumour therapy is successfully applied in everyday practice.
- Dr. Reinhard Becker spoke about the Fasting-Mimicking-Diet and its influence on tumor cell metabolism.
- Dr.-Ing. Bernd Becker spoke about the elimination of resistant tumor cells by ferroptosis with Vit C high dose.
- Biology graduate Maike Winkelmann, health expert and sufferer, reported on her experiences with the Jane McLelland Protocol and the corresponding tests from iQMedix GmbH.
The iQMedix GmbH Therapy Congress, which took place on Saturday, May 10, 2025, proved to be an outstanding event for experts in the field of tumor diagnostics and therapy. The day was characterized by an intensive exchange and scientifically sound contributions that provided the participants with valuable impulses and new knowledge for their own practice.
Feedback from the participants
The positive impressions of the participants reflect the success of the congress .
One participant summarized her experiences as follows:
“Yes, the congress was really great and I was able to take away a lot of knowledge and important impulses for myself. Thank you very much for organizing it.”
A participating doctor also expressed her great pleasure in the event:
“Thank you once again for inviting me to your top-class seminar on Saturday, May 10, 2025. As I am very impressed by the subject matter, I would like to delve deeper into it.”
Another participant emphasized:
“The day was characterized by presentations that were very well coordinated and offered new and effective methods for diagnosing and fighting cancer.”
These statements reflect the high scientific and practice-oriented value of the congress, which provided the experts not only with theoretical but also directly applicable solutions.
Conclusion
Valuable contribution to the further development of tumor diagnostics & therapy
The iQMedix GmbH Therapy Congress provided an outstanding platform for the exchange of knowledge and experience. With its scientifically sound contributions and innovative approaches, it made a valuable contribution to the further development of tumor diagnostics and therapy. The participants left the event inspired and full of ideas for their own practice. Overall, the congress was a complete success, and the positive feedback from participants underlines the importance of such events for specialists.
Ready for personalized diagnostics?
The advantage of personalized diagnostics is that, regardless of the type of cancer, a complete picture of all relevant activities of a tumour is recorded and personalized and targeted therapy options are thus identified for the patient. Tailored to the early stages of the disease, individualized complementary therapy approaches are obtained that are both as effective as possible with as few side effects as possible.
